 "'Experiment on me first': Duterte accepts Russia's Covid-19 vaccine offer")
Philippine President Rodrigo Duterte has accepted Russia’s offer of its coronavirus vaccine, volunteering to take the first shot as a gesture of trust and gratitude.
“When the vaccine arrives, I will have myself injected in public. Experiment on me first, that’s fine with me,” he said in a briefing Monday night. Duterte, who has called President Vladimir Putin as his “idol” and who’s seeking to boost ties with Russia, added that Manila can assist Moscow in clinical trials and local production.
Russia is poised to allow a vaccine developed by Moscow’s Gamaleya Institute for civilian use even before clinical trials are completed, triggering safety warnings from pharmaceutical companies. Russia’s elite has been given the experimental vaccine as early as April.
Russia is poised to allow a vaccine developed by Moscow’s Gamaleya Institute for civilian use even before clinical trials are completed, triggering safety warnings from pharmaceutical companies. Russia’s elite has been given the experimental vaccine as early as April.
The Philippines has 136,638 confirmed coronavirus cases, the highest in Southeast Asia. On Monday, it reported new 6,958 infections, the largest daily increase which the Department of Health attributed to an error in its database that failed to count earlier test results.
Duterte last month said he also asked Chinese President Xi Jinping to help the Philippines get priority access to a Covid-19 vaccine.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%